We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $107M
1-Year Est. Return 82.62%
This Fund
S&P 500
This Quarter Est. Return
+16.08%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$6.09M
Cap. Flow
-$2.2M
Cap. Flow %
-1.95%
Top 10 Hldgs %
41.29%
Holding
90
New
6
Increased
20
Reduced
45
Closed
9

Top Buys

1
TELA icon
TELA Bio
TELA
+$1.92M
2
BLZE icon
Backblaze
BLZE
+$1.21M
3
CYRX icon
CryoPort
CYRX
+$1.1M
4
HAIN icon
Hain Celestial
HAIN
+$1.08M
5
VTRS icon
Viatris
VTRS
+$736K

Top Sells

1
LLY icon
Eli Lilly
LLY
+$2.04M
2
PFIE
Profire Energy, Inc
PFIE
+$1.51M
3
BKSY icon
BlackSky Technology
BKSY
+$972K
4
RMTI icon
Rockwell Medical
RMTI
+$806K
5
AIRG icon
Airgain
AIRG
+$627K

Sector Composition

1 Healthcare 58.33%
2 Technology 24.16%
3 Communication Services 7.82%
4 Consumer Staples 4.49%
5 Industrials 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$38.8B
$8.02M 7.12%
50,675
-3,675
-7% -$535K
LLY icon
2
Eli Lilly
LLY
$1.05T
$7.65M 6.79%
9,910
-2,466
-20% -$2.04M
MSFT icon
3
Microsoft
MSFT
$2.93T
$5.23M 4.64%
12,410
-600
-5% -$256K
INUV icon
4
Inuvo
INUV
$20.6M
$4.58M 4.06%
708,345
+25,559
+4% +$74.2K
AXGN icon
5
Axogen
AXGN
$2.07B
$4.3M 3.82%
261,224
-22,175
-8% -$314K
IDXX icon
6
Idexx Laboratories
IDXX
$44.4B
$4.01M 3.56%
9,700
– –
VCYT icon
7
Veracyte
VCYT
$4.68B
$3.57M 3.17%
90,200
-3,730
-4% -$141K
ELUT icon
8
Elutia
ELUT
$43M
$3.22M 2.85%
860,077
+3,525
+0.4% +$13.7K
LMAT icon
9
LeMaitre Vascular
LMAT
$2.31B
$3.01M 2.67%
32,636
-1,150
-3% -$111K
NEO icon
10
NeoGenomics
NEO
$1.89B
$2.95M 2.62%
178,950
-1,850
-1% -$28.7K
TELA icon
11
TELA Bio
TELA
$34M
$2.74M 2.43%
907,865
+682,665
+303% +$1.92M
OOMA icon
12
Ooma
OOMA
$569M
$2.68M 2.38%
190,409
+22,309
+13% +$297K
ABT icon
13
Abbott
ABT
$173B
$2.53M 2.24%
22,330
-500
-2% -$57.8K
AMD icon
14
Advanced Micro Devices
AMD
$816B
$2.51M 2.23%
20,804
-600
-3% -$86.3K
MDXH icon
15
MDxHealth
MDXH
$21.7M
$2.33M 2.07%
983,475
+236,100
+32% +$482K
QUIK icon
16
QuickLogic
QUIK
$234M
$2.29M 2.03%
202,956
+1,850
+0.9% +$15K
MGNI icon
17
Magnite
MGNI
$2.78B
$2.29M 2.03%
143,825
-5,250
-4% -$77K
CTLP
18
DELISTED
Cantaloupe
CTLP
$2.25M 1.99%
236,350
-8,250
-3% -$75.1K
DGII icon
19
Digi International
DGII
$2.41B
$1.8M 1.6%
59,558
-3,750
-6% -$117K
XGN icon
20
Exagen
XGN
$103M
$1.74M 1.54%
423,721
-35,150
-8% -$127K
BLZE icon
21
Backblaze
BLZE
$807M
$1.72M 1.52%
285,225
+178,390
+167% +$1.21M
ATEC icon
22
Alphatec Holdings
ATEC
$1.32B
$1.67M 1.48%
181,567
+900
+0.5% +$7.18K
BDSX icon
23
Biodesix
BDSX
$205M
$1.62M 1.44%
53,011
+16,772
+46% +$493K
VCEL icon
24
Vericel Corp
VCEL
$2.4B
$1.52M 1.35%
27,650
-1,600
-5% -$81K
PSNL icon
25
Personalis
PSNL
$1.61B
$1.49M 1.32%
257,307
– –
1
2 3 4

Similar funds

EWL
Emissary Wealth LLC Hackensack, New Jersey $107M AUM
ECM
Explore Capital Management Wilmington, Delaware $107M AUM 19.23% 1-Year Est. Return
HCA
Hardworking Capital Advisors Palm Desert, California $107M AUM
CWM
Curtis Wealth Management Henderson, Nevada $107M AUM
SNPAM
St. Nicholas Private Asset Management Jacksonville, Florida $107M AUM 13.98% 1-Year Est. Return
TWM
Tortuga Wealth Management Torrance, California $107M AUM
ACL
APEIRON Capital Ltd Hong Kong $107M AUM 9.59% 1-Year Est. Return
FMI
Financial Management Inc Little Rock, Arkansas $106M AUM

Perkins Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Perkins Capital Management held 90 positions worth $113M, up 5.7% from $107M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Perkins Capital Management's Q4 2024 filing shows 6 new, 20 increased, 45 reduced and 9 closed positions. Its largest new stake was Hain Celestial: 135,213 shares worth $832K. The largest sale was Eli Lilly, an estimated $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q4 2024 buy was Hain Celestial: 135,213 shares worth $832K.
  • Perkins Capital Management added most to TELA Bio in Q4 2024, an estimated $1.92M increase.
  • Perkins Capital Management's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.04M.
  • Perkins Capital Management fully exited Profire Energy, Inc in Q4 2024, selling an estimated $1.51M.
  • Perkins Capital Management's ten largest holdings make up 41% of its $113M portfolio in Q4 2024.
  • Perkins Capital Management opened 6 new positions and closed 9 in Q4 2024.
  • Perkins Capital Management's portfolio value rose 5.7% quarter-over-quarter to $113M.

Based on Perkins Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.